TradeFlare's AI research teams analysed STTK on 9 market nights between May 5, 2026 and August 31, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| August 31, 2026 | BUY | $7.04 | $8.80 / $5.28 | -7.3% | -6.7% | The bullish fundamental and sentiment outlook, combined with a technical oversold signal, suggests a potential recovery over a few weeks. |
| July 1, 2026 | BUY | $6.94 | $8.10 / $5.73 | +8.0% | +10.4% | The post-earnings drift signal suggests momentum could persist for several weeks. |
| May 15, 2026 | HOLD | $6.67 | — / — | -2.6% | -26.0% | The current market conditions and the stock's technical setup do not present a clear, high-conviction trading opportunity. |
| May 14, 2026 | BUY | $6.75 | — / — | -8.7% | -25.9% | The stock is consolidating near resistance with mixed technical signals, requiring a clearer breakout before considering a trade. |
| May 13, 2026 | BUY | $6.62 | $7.66 / $5.63 | -8.6% | -38.1% | The stock is currently trading near resistance, and the risk/reward ratio is not favorable enough for a buy in this neutral market. |
| May 8, 2026 | BUY | $6.26 | — / — | -8.6% | -43.1% | Positive clinical trial data for pipeline candidates. |
| May 7, 2026 | BUY | $6.68 | — / — | +6.5% | -26.8% | The current market conditions and the stock's technical and fundamental profile do not present a clear high-conviction trading opportunity. |
| May 6, 2026 | BUY | $6.54 | $7.69 / $5.56 | +1.1% | -28.1% | The stock is in a neutral market regime and requires a clear catalyst for a buy, with the current price near resistance. |
| May 5, 2026 | HOLD | $6.92 | — / — | +1.2% | -27.4% | Successful progression of clinical trials for key drug candidates. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.